SecBot SecBot

CHE

CHEMED CORP
NYSE· Services-Home Health Care Services· Inc. DE· CIK 0000019584 Healthcare & Medical Devices
$549.45 +1.25 (+0.23%)
Nov 16 4:00 PM ET · prev $548.20
Market cap
$7.2B
Mid cap
Consensus
Buy
67% Buy or better · 9 analysts
Median target
$620.00
+13% · range $580.00–675.00
1 year
+27.1%
from $432.38 · Nov 17
30 days
+8.1%
from $508.29
52-week range
$368.59–552.72
−1% from high · low Mar 27
Avg volume 20D
161.6K
shares / day
Short interest
796.0K
≈6.1% of shares · +16.0%
Days to cover
5.0
at average volume
Insider net
−$10.0M
0 buyers · 5 sellers · since Feb 13
New fund stakes
2
Q3 2026 13F · 4 exits
Filing reports
16
analyzed by SecBot
SecBot read MIXED 10 reports · 90 days
Balance 1 bearish · 2 bullish · 2 mixed · 5 neutral oldest → newest, height = score
Avg score ·High conf. 8/10

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    5 insiders sold $10.0M.

  • InstitutionsMIXED

    Q3 2026: 32 added (2 new), 31 trimmed or exited. Largest new: Assenagon Asset Management S.A $21.9M.

  • AnalystsBULLISH

    6 of 9 rate it Buy or better. Every target is above the price.

  • Short sellersBUILDING

    Short interest +16.0% to 796.0K shares. 5.0 days to cover, ≈6.1% of shares.

  • TrendUPTREND

    6% above its 50-day average.

Who's buying

13F· Q3 2026
2
new positions
4
exits
$21.9M
in new stakes · top 1 shown
FundMoveSharesValue
Boston PartnersADD376,995$190.4M
FIRST TRUST ADVISORS LPTRIM146,423$74.0M
Qube Research & Technologies LtdDOUBLED108,570$54.8M
LOS ANGELES CAPITAL MANAGEMENT LLCDOUBLED46,461$23.5M
Assenagon Asset Management S.A.NEW43,304$21.9M
BARCLAYS PLCDOUBLED37,644$19.0M
BANK OF NOVA SCOTIADOUBLED35,013$17.7M
PUBLIC SECTOR PENSION INVESTMENT BOARDADD27,196$13.7M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 67% rate it Buy or better
Strong Buy3Buy3Hold3Sell0Strong Sell0
12-month targets · 5 analysts

Price is below the lowest target. Median implies +13%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Oct 29, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform
Oct 29, 2026UBS
MAINTAIN
MAINTAINBuy
Oct 29, 2026Oppenheimer
MAINTAIN
MAINTAINOutperform
Oct 28, 2026Jefferies
UPGRADE
UPGRADEBuy
Sep 25, 2026UBS
INITIATE
INITIATEBuy
Jul 31, 2026Oppenheimer
MAINTAIN
MAINTAINOutperform

Insider ledger

Form 4
$0
bought · 0 insiders
$10.0M
sold · 5 insiders
DateInsiderTypeValue
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
GIFT
Nov 11, 2026
LEE SPENCER S
executive vice president
Nov 11, 2026
SELL$547.6K
Nov 3, 2026
MCNAMARA KEVIN J
president and CEO
Nov 3, 2026
SELL$1.1M
Nov 2, 2026
LEE SPENCER S
executive vice president
Nov 2, 2026
SELL$494.2K
Oct 20, 2026
HUTTON THOMAS C
vice president
Oct 20, 2026
AWARD$2.0M
Oct 20, 2026
MCNAMARA KEVIN J
president and CEO
Oct 20, 2026
AWARD$18.8M
Oct 20, 2026
LEE SPENCER S
executive vice president
Oct 20, 2026
AWARD$3.7M
Oct 20, 2026
Witzeman Michael D
VP & Chief Financial Officer
Oct 20, 2026
AWARD$6.5M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
795,988
shares short
+16.0%
vs prior settlement
5.0
days to cover
≈6.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

16 filings · 3 press releases · 4 bullish · 1 bearish · 4 mixed · 7 neutral
All CHE filing & press-release reports (19)